Regest 160 Tablet

Introduction

Regest is a prescription medication that contains the active ingredient Megestrol. It is available under the brand name Regest.

Uses

Regest is primarily prescribed for the treatment of certain hormone-responsive cancers, such as breast cancer or endometrial cancer. It may also be used to manage symptoms associated with advanced breast or endometrial cancer, including loss of appetite and weight loss.

Dosage and Administration

The dosage of Regest will vary depending on the specific condition being treated and individual patient factors. Follow the instructions provided by your healthcare professional. Generally, the recommended dose for adults is 160 mg taken once daily. The tablet should be swallowed whole with a glass of water, with or without food.

Mechanism of Action

The active ingredient in Regest, Megestrol, belongs to a class of medications called progestins. It works by binding to progesterone receptors in the body, which can help slow down the growth of hormone-responsive cancer cells. Additionally, Megestrol may stimulate appetite and promote weight gain in individuals experiencing loss of appetite or weight loss associated with certain cancers.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, dizziness, headache, and fluid retention. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, consult your healthcare professional.

Serious side effects of Regest are rare but may include blood clots, abnormal vaginal bleeding, mood changes, and allergic reactions. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Regest may interact with other medications, including blood thinners, certain antifungal medications, and certain antibiotics. Inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. They can provide guidance on potential drug interactions and adjust your treatment plan accordingly.

Precautions

Before taking Regest, inform your healthcare professional about any known allergies, medical conditions, or medications you are currently taking. This medication may not be suitable for individuals with a history of certain medical conditions, such as blood clots or liver disease.

Regest may interact with other medications, including hormonal contraceptives and certain anticoagulants. Discuss all potential interactions with your healthcare professional to ensure safe and effective use of this medication.

Storage

Regest should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of the reach of children and pets. Do not use the medication if it has passed its expiration date or if the packaging is damaged.

Patient Tips

• Take Regest exactly as prescribed by your healthcare professional.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not stop taking Regest without consulting your healthcare professional, as this may affect the effectiveness of your treatment.
• If you experience any new or worsening symptoms while taking Regest, contact your healthcare professional for further evaluation.
• attend regular follow-up appointments with your healthcare professional to monitor your response to the medication and adjust your treatment plan if necessary.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Megestrol (Drugs.com) [Accessed 5 Jun. 2024] (online) Available at:
• megestrol acetate (RX) [Accessed 15 Jun. 2024] (online) Available at:
• Megestrol (MedlinePlus) [Accessed 24 Jun. 2024] (online) Available at:
• Canetta R, Florentine S, Hunter H, Lenaz L. Megestrol acetate. Cancer Treat Rev. 1983 Sep;10(3):141-57. doi: 10.1016/0305-7372(83)90029-4. [Accessed 21 Jun. 2024] Available at: